Results 151 to 160 of about 346,440 (204)

Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summary. [PDF]

open access: yesFuture Oncol
González-Martín A   +17 more
europepmc   +1 more source

Chemotherapy-induced cardiotoxicity in cancer patients: an observational study at an Oncology reference hospital from southeastern Brazil. [PDF]

open access: yesRev Lat Am Enfermagem
Neumann K   +5 more
europepmc   +1 more source

Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials. [PDF]

open access: yesCancer Res Commun
Zhang H   +11 more
europepmc   +1 more source

Mortalidad prematura por cáncer en Mallorca [PDF]

open access: yes, 1999
Cabeza Irigoyen, Elena   +4 more
core  

Home - About - Disclaimer - Privacy